COMMUNIQUÉS West-GlobeNewswire
-
Poseida Therapeutics to Present anti-PSMA CAR-T Preclinical Data at the Society for Immunotherapy of Cancer (SITC) 32nd Annual Meeting
08/11/2017 - 14:00 -
Imaging for Women Now Offering iCAD’s PowerLook® Tomo Detection for Digital Breast Tomosynthesis
08/11/2017 - 14:00 -
AMAG Announces Autologous Cord Blood Cells Improve Motor Function in Some Children with Cerebral Palsy
08/11/2017 - 14:00 -
Microbot Medical Inc. Receives Additional Government Grant for Development of its Self-Cleaning Shunt
08/11/2017 - 14:00 -
Nuvus.io Building the New Global Exchange for Cannabis Industry with Distributed ledger/Blockchain Platform Nuvus Protocol – An Irrefutable Chain of Custody Audit for the Seed to Patient using Private & Public Blockchains
08/11/2017 - 13:31 -
Avadel Pharmaceuticals Reports Third Quarter 2017 Results
08/11/2017 - 13:30 -
Intra-Cellular Therapies Reports Third Quarter 2017 Financial Results and Provides Corporate Update
08/11/2017 - 13:30 -
G1 Therapeutics Reports Third Quarter 2017 Financial Results and Recent Operational Highlights
08/11/2017 - 13:30 -
Exonics Therapeutics Raises $40 Million in Series A Financing
08/11/2017 - 13:30 -
Fortress Biotech Announces Cellvation’s CEVA101 Granted FDA Regenerative Medicine Advanced Therapy Designation for the Treatment of Traumatic Brain Injury
08/11/2017 - 13:30 -
Cancer Genetics to Present Insights to Advance Precision Medicine in Non-Small Cell Lung Cancer (NSCLC) at AMP Annual Meeting 2017
08/11/2017 - 13:30 -
Nextech Achieves 2015 Edition ONC-Health IT Certification
08/11/2017 - 13:30 -
Alimera Sciences Announces Nine iluvien® data sets to be Presented at 2017 american academy of ophthalmology
08/11/2017 - 13:30 -
Tyme Provides Clinical and Corporate Update for the Fiscal First Half 2017
08/11/2017 - 13:30 -
Neuralstem Strengthens Executive Leadership Team with Appointment of Dr. David Recker as Chief Medical Officer
08/11/2017 - 13:30 -
TG Therapeutics, Inc. Provides Business Update and Reports Third Quarter 2017 Financial Results
08/11/2017 - 13:30 -
Immunovaccine Announces Regulatory Clearance for Phase 2 Clinical Trial Evaluating DPX-Survivac in Combination with Merck’s Checkpoint Inhibitor Pembrolizumab in DLBCL
08/11/2017 - 13:05 -
AroCell AB: Abstract published presenting AroCell TK 210 ELISA from the PROMIX study at the European Society for Medical Oncology Congress in Singapore, November 17-19, 2017
08/11/2017 - 09:31 -
Lundbeck increased operating profit (EBIT) with 126% and EPS by 182% in the first nine months of 2017
08/11/2017 - 07:45
Pages